Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 1,140Congress 29Executive branch 6Insiders 1,105
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

buys only · $1M+ · 1,140 trades

Trades
1,140
Buys 1,140 · Sells 0
People
336
Stocks
204
Disclosed value
$10.4B
range midpoints · Congress & executive
Filed late
160
  1. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  2. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  3. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  4. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  5. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  6. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  7. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  8. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  9. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  10. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  11. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  12. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  13. ▲ BUYTomas Kiselak DirectorCBIO Crescent Biopharma, Inc.$12.4Mdisclosed Jul 20 · filed 4 days after the trade 1 rule fired
  14. ▲ BUYPeter Evan Harwin DirectorCBIO Crescent Biopharma, Inc.$12.4Mdisclosed Jul 20 · filed 4 days after the trade 1 rule fired
  15. ▲ BUYMichael Heinrich Executive ChairmanZSTK ZeroStack Corp.$3.5Mdisclosed Jul 20 · filed the same day
  16. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
  17. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$3.7Mdisclosed Jul 20 · filed 7 days after the trade · late
  18. ▲ BUYFairmount Funds Management LLC DirectorCBIO Crescent Biopharma, Inc.$12.4Mdisclosed Jul 20 · filed 4 days after the trade 1 rule fired
  19. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
  20. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
  21. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
  22. ▲ BUYFairmount Healthcare Fund II L.P. DirectorCBIO Crescent Biopharma, Inc.$12.4Mdisclosed Jul 20 · filed 4 days after the trade 1 rule fired
  23. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$3.2Mdisclosed Jul 20 · filed 11 days after the trade · late
  24. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
  25. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade